Ikena Oncology - IKNA Future Profit

IKNA (Ikena Oncology Inc.) - company brandmark

Ikena Oncology, Inc. (IKNA) is developing a targeted therapy system by reprogramming tumor cells. On GURU.Markets, the consensus profit forecast chart visualizes this driver, where shows the current value of the metric. Market capitalization relies on insurance reimbursements for metabolic drugs. However, clinical disappointments have forced the company to shift its market strategy toward seeking a favorable merger.

IKNA: Ikena Oncology, Inc. Future Profit 07/04/2022 - 11/18/2026

Ikena Oncology Inc. - analytical breakdowns and key metrics (IKNA)

- price and consensus price forecast:
Fundamental company analysis:Ikena, IKNA
Core merchandise of Ikena Oncology

Projected earnings measure market expectations for future cash flows by discounting potential revenues to present value. Investors utilize this indicator to assess the fair value of a business relative to its prospects. The price action based on the future earnings model reflects market confidence in the success of the strategic portfolio review at Ikena Oncology, Inc. (IKNA). The concentration of resources on a target molecule for gastric cancer treatment directly determines the trend of this metric. An increase in this metric confirms a high probability of commercializing the new drug.

Competitor analysis

Future Profit ONC|HALO: Expected Net Income|Future Profit RVMD (RevMed)|AAPG (Ascentage) - Expected Net Income|Projected Future Earnings CGON (cgoncology.com)|URGN - Future Profit|BCAX: Future Profit|PSNL - Projected Future Earnings|Erasca Corp (ERAS) - Expected Profit|Delcath - Expected Net Income|YMAB (Y-mAbs Therapeutics Inc) - Projected Future Earnings|Expected Net Profit Aura Biosciences, Inc. AURA|Projected Future Earnings CADL|Projected Future Earnings Accuray (ARAY)|Expected Profit SELLAS Life Sciences Group Inc. SLS|ACTU - Future Profit|CTOR: Future Profit|Expected Net Income HURA (TuHURA Biosciences Inc.)|TARA (Protara Therapeutics) - Future Profit|Expected Net Profit Fate Therapeutics Corp (FATE)|Future Profit WHWK|Net Profit Forecast TCRX (TScan Therapeutics, Inc.)|Projected Future Earnings CSBR|XBIT - Expected Net Profit|CEL-SCI Corporation - Future Profit|Expected Net Income OSTX|radiopharmtheranostics.com - Projected Future Earnings|ARTV: Expected Profit|ANL (adlainortye.com) - Future Profit|VERU - Company Profit Forecast|TPST (Tempest Therapeutics, Inc.) - Projected Future Earnings|Projected Future Earnings xiliotx.com|Expected Profit Enochian BioSciences (RENB)|Expected Profit MURA (Mural Oncology PLC)|Expected Profit Kairos Pharma Ltd KAPA|Projected Future Earnings OnKure Therapeutics Inc OKUR|CytoMed Therapeutics - Projected Future Earnings|Company Profit Forecast Curis CRIS|APLM: Projected Future Earnings|Future Profit Tharimmune, Inc.|ADVB (Advanced Biomed) - Projected Future Earnings|Genprex - Forward Earnings|Expected Profit calidibio.com (CLDI)|SBFM (Sunshine Biopharma Inc.) - Expected Net Income|Projected Future Earnings XBIO (Xenetic Biosciences)|Salarius Pharmaceuticals (SLRX) - Expected Net Profit|PPBT: Future Profit|Expected Net Income AONC (American Oncology Network, Inc.)|BeOne Medicines (BGNE) - Expected Profit|Checkpoint Therapeutics, Inc (CKPT) - Projected Future Earnings|Expected Profit Elevation Oncology, Inc.|ICAD: Expected Net Income|Expected Profit Notable Labs, Ltd. (NTBL)|Expected Profit VIRX (Viracta Therapeutics, Inc.)|Projected Future Earnings MOR (MorphoSys Inc)|Projected Future Earnings NAYA Biosciences Inc NAYA|AAPGV - Expected Profit